Archiv: licensing


02.07.2021 - 14:34 [ DailyMail.co.uk ]

Up to 5million British holidaymakers could be BARRED from Europe because they were given Indian-made versions of AstraZeneca Covid jab

– EMA does not recognise the Covishield AstraZeneca vaccine produced in India
– This could cause issue for vaccinated Britons eagerly hoping to travel abroad
– Still a theoretical issue as so few European nations are on the ‚green‘ travel list

02.07.2021 - 13:47 [ Express.co.uk ]

Astrazeneca batch number check: How to check where your AZ jab was made

The EU’s passport scheme does not recognise batches of AstraZeneca that were made in India and given out in the UK.

The EU Digital Covid Certificate will allow people to travel safely across Europe by acting as a Covid passport.

25.06.2020 - 18:43 [ theGuardian.pe.ca ]

Gilead‘s remdesivir set to become Europe‘s first COVID-19 therapy

The European Medicines Agency (EMA) said on Thursday its human medicines committee (CHMP) recommended conditionally approving the drug for adults and adolescents from 12 years of age who are also suffering from pneumonia and require oxygen support. (https://bit.ly/3i3O6Ck)

European Union conditional marketing authorisation allows a treatment to be sold for a year in the 27-nation bloc before all necessary data on its efficacy and side-effects are available. Gilead has until December to submit this data.

15.03.2020 - 22:51 [ Genetic Engineering and Biotechnology News - genengnews.com ]

CureVac, Sanofi Pasteur, and In-Cell-Art Collaborate on €33.1M DARPA-Supported Vaccine Program

(November 15, 2011)

The four-year DARPA-supported program will exploit CureVac’s RNActive technology along with In-Cell-Art’s nanoparticle expertise and Sanofi’s vaccine development capabilities.

The option agreement signed between Sanofi and CureVac in parallel with the DARPA collaboration covers pre-agreed license terms for the development of vaccines against a number of predefined pathogens.

24.08.2019 - 12:34 [ SpaceNews.com ]

Administration policies seek to promote use of space nuclear power

A revised policy for approving the launch of spacecraft with nuclear power systems is the latest measure intended to support greater use of nuclear power systems in orbit and beyond.

The policy, formally issued by President Trump Aug. 20 to coincide with the latest public meeting of the National Space Council, updates guidelines for how both government and commercial spacecraft carrying space nuclear systems are reviewed and approved for launch.

24.08.2019 - 12:32 [ Weißes Haus ]

Presidential Memorandum on Launch of Spacecraft Containing Space Nuclear Systems

This memorandum establishes processes for Federal Government launches and launches for which the Department of Transportation (DOT) has statutory authority to license as commercial space launch activities (commercial launches). These processes include transparent safety guidelines and are forward-looking and amenable to effective use of space nuclear systems for heating, power, and propulsion.